According to new medical guidelines published by JAMA Internal Medicine, popular weight loss medications such as Ozempic and Wegovy require thoughtful lifestyle management to protect muscle mass and ensure proper nutrition.
GLP-1 receptor agonists can produce an impressive 15-21% weight loss, but doctors now recognize that these drugs work best when paired with personalized nutrition and physical exercise programs. Without proper guidance, patients may lose muscle mass, develop nutritional deficiency or suffer from troubled side effects.
“While GLP-1 RAS represents a major breakthrough in obesity management, enduring therapeutic success requires integration of medication with personalized nutrition and physical exercise interventions,” explains Dr. Joann E. Manson of Harvard Medical School.
Keep muscles and lose fat
The study revealed a statistics that up to 40% of weight loss due to GLP-1 drugs may come from muscle rather than fat tissue. Muscle loss may be particularly problematic for older people or already limited muscle mass.
Good news? Regular resistance training can greatly reduce this problem. Research on similar weight loss methods shows that strength training can retain 50-95% of muscle, which would have been lost.
- Aim at 60-90 minutes of resistance training per week (2-3 meetings)
- Combined with 150 minutes of moderate aerobic activity every week
- Start slowly and gradually increase intensity, especially when tired
- Consider tracking muscle strength through simple tests, etc.
A wise dietary strategy can prevent nutritional gaps
Patients taking GLP-1 medications often experience a significant reduction in appetite, which can bring about new dietary challenges. The authors recommend emphasizing nutrient quality rather than focusing on calorie restrictions (these drugs already help these drugs).
“Clinicians should emphasize the importance of nutritional quality to rigid calorie counts,” the researchers noted.
The paper introduces a useful meal framework: maintaining muscle with enough protein; energy balance, smaller, nutritious meals; avoiding side effects through specific food choices; 2-3 liters of liquid intake per day to prevent dehydration.
Manage the drug journey
The researchers also provided guidance to monitor weight loss progress. For those who lose weight too slowly (less than 5% after 12-16 weeks), doctors should evaluate medication adherence and consider adjusting doses or alternative medications.
On the contrary, excessive weight loss requires timely attention. Warning signs include BMIs that consume less than 800 calories per day, protein intake is very low or drop below 18.5. In these cases, doctors should look at potential causes and consider reducing drug dosage.
Weight recovery after stopping these drugs is common, and patients usually recover 7-12% of their body weight within a year of interruption. When treating shrink medication, doctors should monitor the patient closely and consider restarting treatment if their weight returns to more than 5%.
“Obacteria is a chronic disease that usually requires long-term management, similar to hypertension,” the author stresses the importance of treating these drugs as ongoing care rather than temporary solutions.
By combining medication with tailored nutrition and exercise programs, patients can achieve more sustainable weight management while protecting their overall health and quality of life.
Related
If our report has been informed or inspired, please consider donating. No matter how big or small, every contribution allows us to continue to provide accurate, engaging and trustworthy scientific and medical news. Independent news takes time, energy and resources – your support ensures that we can continue to reveal the stories that matter most to you.
Join us to make knowledge accessible and impactful. Thank you for standing with us!
